Contrast Media Injectors Market

Report Overview

The global contrast media injectors market was pegged at US$ 1.41 billion in 2020 and is expected to witness a CAGR of 7.1% during the forecast period.

Market Fundamentals

Contrast media injectors are medical devices used for injecting radio-opaque contrast media into the body to enhance the visibility of tissues during a medical imaging procedure. It is used for imaging procedures such as X-rays, CT, and MRI. It permits visibility-enhancing substances/contrast media to be introduced at targeted locations within the human body. The presence of these substances makes it possible to produce images that readily distinguish one set of tissue from another.

[735224]

Market Dynamics

The global contrast media injectors market is mainly driven by the rising incidence of chronic diseases such as cancer and cardiovascular disease coupled with the growing geriatric population, technological advancements, and government initiatives. However, the high cost of contrast media injectors and product recalls are likely to restrain the market growth to a certain extent.

Market Ecosystem

The global contrast media injectors market has been analyzed from four perspectives: Product, Application, End-User, and Region.

Contrast Media Injectors Market by Product

Based on product, the contrast media injectors market has been segmented into consumables, injector systems, and accessories. The consumables segment is further categorized into syringes, tubes, injector heads, and others. The injector systems segment is further categorized into angiography injector system, CT injector system, and MRI injector system. The consumables segment dominated the market with the largest share in 2020. The growth of the segment can be attributed to the frequent purchase of disposable syringes and tubes for each procedure, owing to the rising demand to maintain safety and hygienic conditions during diagnostic procedures.

Contrast Media Injectors Market by Application

Based on application, the contrast media injectors market has been segmented into radiology, interventional cardiology, and other applications. The interventional cardiology segment dominated the market with the largest share in 2020, wing to the rising prevalence of cardiovascular diseases such as arrhythmia, stroke, and heart attack.

Contrast Media Injectors Market by End User

[98655324]

Based on end-user, the contrast media injectors market has been segmented into hospitals, diagnostic centers, and others. The diagnostic center's segment is expected to be the fastest-growing application segment during the forecast period. The growth of the segment can mainly be attributed to the increasing number of diagnostic centers and lower imaging costs as compared to hospitals.

Contrast Media Injectors Market by Region

Based on region, the global contrast media injectors market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the contrast media injectors market with the largest share in 2020, followed by the Asia Pacific. The large share of North America in the global market can be attributed to the growing burden of chronic diseases, rapid adoption of technologically advanced products, and developed healthcare infrastructure. Moreover, the presence of a large number of prominent players and their collaboration to develop and launch advanced imaging technologies are also expected to boost the market.

Competitive Landscape

Some of the prominent players operating in the contrast media injectors market includes:-

• Bayer
• Bracco Imaging S.p.A
• Nemoto Kyorindo co., Ltd
• ulrich GmbH & Co. KG
• Shenzhen Anke High-tech Co., Ltd
• Medtron AG
• Apollo RT Co. Ltd
• Sinomdt
• Guerbet
• Shenzhen Seacrown Electromechanical Co., Ltd., among others

Strategic Developments

• In November 2019, Leriva expanded collaboration with the Bracco Group. As per the agreement, with effect from January 2020, Leriva's Imaging and Contrast Media business unit would market Bracco's contrast injectors along with the associated consumables.
• In September 2019, Bayer launched its Medrad Stellant Flex CT injection system. Stellant Flex is a user-driven system that requires minimal technologist training and automation. It offers individualized patient protocols and personalized imaging with flexible options for capital equipment through the company's TechCare program.
• In November 2017, Guerbet announced the launch of Contrast&Care, a new contrast media injection management solution for radiology centers.

Frequently Asked Questions About This Report